vegf165 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
vegf165
Vegf165, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 885 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+vegf165/Recombinant+Human+VEGF+165+Protein/pm41807626-59-46-56
Average 96 stars, based on 885 article reviews
Vegf165, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 885 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+vegf165/Recombinant+Human+VEGF+165+Protein/pm41807626-59-46-56
Average 96 stars, based on 885 article reviews
vegf165 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Recombinant:Article Title: Endothelial cell invasiveness is controlled by myosin IIA-dependent inhibition of Arp2/3 activity Article Snippet: Briefly, HUVECs were plated in 100 mm dishes, previously coated with fibronectin (10μg/ml, Sigma-Aldrich), until they reach the confluence. .. Cells were then starved overnight in serum-free medium, treated with (−)-Blebbistatin (50μM, Sigma-Aldrich) during 2 hours and stimulated with human Article Title: Androgens Stimulate EPC-Mediated Neovascularization and Are Associated with Increased Coronary Collateralization. Article Snippet: .. Article Title: CAMKII as a therapeutic target for growth factor-induced retinal and choroidal neovascularization. Article Snippet: .. Article Title: Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein. Article Snippet: Fenofibrate, a peroxisome proliferator–activated receptor a (PPARa) agonist, reduces lower limb amputations in patients with type 2 diabetes.. The mechanism is, however, unknown.. In this study, we demonstrate that fenofibrate markedly attenuates diabetes-related impairment of ischemia-mediated angiogenesis. Article Title: Endothelial cell invasion is controlled by dactylopodia Article Snippet: Briefly, HUVECs were plated in 100 mm dishes, previously coated with fibronectin (10μg/ml, Sigma-Aldrich), until they reach the confluence. .. Cells were then starved overnight in serum-free medium, treated with (−)-Blebbistatin (50μM, Sigma-Aldrich) during 2 hours and stimulated with human Article Title: Endothelial Tip Cell Invasive Behaviour During Sprouting Angiogenesis is Controlled by Myosin IIA-Dependent Inhibition of Arp2/3 Activity Article Snippet: Affiliations: 1 Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.. 2 Institut Curie, PSL Research University, CNRS UMR144, F-75005 Paris, France.. 3 INSERM U932, Institut Curie, ANR-10-IDEX-0001-02 PSL(∗) and ANR-11-LABX0043, Paris, France. Article Title: Analysis of Bevacizumab Activity Following Treatment of Patients with Ovarian Cancer or Glioblastoma Article Snippet: .. The capture enzyme-linked immunosorbent assay (ELISA) for the quantification of bevacizumab using microtiter plates were coated overnight with human Article Title: A stabilized CXCL9(74-103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate. Article Snippet: Glycosaminoglycans/proteoglycans (GAGs/PGs) regulate numerous molecular and cellular interactions during tumor progression, and are as such potentially interesting targets for anti-cancer therapy.. We previously demonstrated that an L-amino acid GAG-binding peptide derived from CXCL9, CXCL9(74–103), acted angiostatically.. Here, we tested whether a CXCL9(74–103) version fully consisting of D-amino acids, to provide protease resistance and stability, retained its anti-angiogenic properties. Migration:Article Title: Androgens Stimulate EPC-Mediated Neovascularization and Are Associated with Increased Coronary Collateralization. Article Snippet: .. Article Title: Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein. Article Snippet: Fenofibrate, a peroxisome proliferator–activated receptor a (PPARa) agonist, reduces lower limb amputations in patients with type 2 diabetes.. The mechanism is, however, unknown.. In this study, we demonstrate that fenofibrate markedly attenuates diabetes-related impairment of ischemia-mediated angiogenesis. Pore Size:Article Title: Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein. Article Snippet: Fenofibrate, a peroxisome proliferator–activated receptor a (PPARa) agonist, reduces lower limb amputations in patients with type 2 diabetes.. The mechanism is, however, unknown.. In this study, we demonstrate that fenofibrate markedly attenuates diabetes-related impairment of ischemia-mediated angiogenesis. Enzyme-linked Immunosorbent Assay:Article Title: Analysis of Bevacizumab Activity Following Treatment of Patients with Ovarian Cancer or Glioblastoma Article Snippet: .. The capture enzyme-linked immunosorbent assay (ELISA) for the quantification of bevacizumab using microtiter plates were coated overnight with human Blocking Assay:Article Title: A stabilized CXCL9(74-103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate. Article Snippet: Glycosaminoglycans/proteoglycans (GAGs/PGs) regulate numerous molecular and cellular interactions during tumor progression, and are as such potentially interesting targets for anti-cancer therapy.. We previously demonstrated that an L-amino acid GAG-binding peptide derived from CXCL9, CXCL9(74–103), acted angiostatically.. Here, we tested whether a CXCL9(74–103) version fully consisting of D-amino acids, to provide protease resistance and stability, retained its anti-angiogenic properties. |